Philippine industry submits plan for massive price cuts
This article was originally published in Scrip
Executive Summary
13 drug companies in the Philippines, including major research-based multinationals, have now submitted formal proposals to the department of health (DoH) which would see prices for selected major drugs slashed by at least 50%.